Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v33-EN Version v27-EN
Language English English
Date Updated 2019-02-05 2019-01-30
Drug Identification Number 00042579 00042579
Brand name MAXIDEX MAXIDEX
Common or Proper name MAXIDEX OINTMENT 3.5MG MAXIDEX OINTMENT 3.5MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients DEXAMETHASONE DEXAMETHASONE
Strength(s) 0.1% 0.1%
Dosage form(s) OINTMENT OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3.5MG 3.5MG
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-09-10 2018-09-10
Actual start date 2018-09-10 2018-09-10
Estimated end date 2019-02-04 2019-02-01
Actual end date 2019-02-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Maxidex 0.1% Suspension 5ml is available (#742021) Maxidex 0.1% Suspension 5ml is available (#742021)
Health Canada comments